Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Lowering testosterone speeds up wound healing in male mice.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Overexpressing the mineralocorticoid receptor in mouse skin causes skin thinning, early skin barrier development, eye issues, and hair loss.

RANK-RANKL signaling is essential for hair growth and skin health.

miR-22, a type of microRNA, controls hair growth and its overproduction can cause hair loss, while its absence can speed up hair growth.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Mice that can regenerate tissue have cells that pause in the cell cycle, which is important for healing, similar to axolotls.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Estrogen increases blood vessel growth factor production, while testosterone blocks this increase.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Dermal papilla cells are key for hair growth and color, influencing hair type and size, and their interaction with stem cells could help treat hair loss and color disorders.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Different types of skin stem cells can change and adapt, which is important for developing new treatments.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

The vitamin D receptor has many roles in the body beyond managing calcium, affecting the immune system, hair growth, muscles, fat, bone marrow, and cancer cells.